Research / Stocks / IIIV IIIV Nasdaq CIK 0001728688
i3 Verticals, Inc. · Services-Prepackaged Software
RESEARCH CURRENTCOVERAGE / STANDARD
Latest filing 10-Q · Aug 7, 2026
Research state Latest filing analysis is current
Last SEC check Sep 13, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT i3 Verticals, Inc.'s latest supported as-filed period reports revenue of $53.1M , 2.2% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Capex intensity 100th Own-history percentile · N=12
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.47% · OPTIONAL
Operating cash generation 100th Own-history percentile · N=12
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 26.88% · OPTIONAL
Revenue growth 100th Own-history percentile · N=8
Method Yoy · gp.fundamentals.revenue
Raw value 2.25% · CORE
Inventory pressure 92th Own-history percentile · N=12
Method Level · gp.fundamentals.inventory_revenue_ratio
Raw value 5.27% · OPTIONAL
Operating margin 8th Own-history percentile · N=12
Method Level · gp.fundamentals.operating_margin
Raw value -1.68% · CORE
SBC intensity 83th Own-history percentile · N=12
Method Level · gp.fundamentals.sbc_revenue_ratio
Raw value 9.68% · OPTIONAL
Inspect state history and evidence → 6 dimension transitions in this filing Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jun 30, 2026 General Corporate
Capital Allocation 3 evidence-backed dimensions Capex Intensity Increasing Cash Generation Inflecting Sbc Intensity Inflecting [email protected] · 13 historical states · 38% confidenceCompany Direction 6 evidence-backed dimensions Capex Intensity Increasing Cash Generation Inflecting Inventory Pressure Inflecting Profitability Inflecting Sbc Intensity Inflecting [email protected] · 13 historical states · 38% confidenceFinancial Quality 4 evidence-backed dimensions Cash Generation Inflecting Inventory Pressure Inflecting Profitability Inflecting Sbc Intensity Inflecting [email protected] · 13 historical states · 38% confidenceGovernance Evidence 3 evidence-backed dimensions Filing Amendments Observed Auditor Changes None Detected Sbc Intensity Observed [email protected] · 13 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Capex Intensity
IIIV 2.5
Peer median 0.9
Peer percentile 76th 124 valid peers · 79% coverage · +1.4 robust σ Growth
IIIV 2.2
Peer median 10.7
Peer percentile 28th 129 valid peers · 82% coverage · -0.6 robust σ Cash Generation
IIIV 26.9
Peer median 16.4
Peer percentile 71th 143 valid peers · 91% coverage · +0.5 robust σ Sbc Intensity
IIIV 9.7
Peer median 10.9
Peer percentile 45th 142 valid peers · 90% coverage · -0.1 robust σ Profitability
IIIV -1.7
Peer median -1.8
Peer percentile 50th 148 valid peers · 94% coverage · +0.0 robust σ Open group breadth → Divergence is context, not positive or negative. Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001728688-26-000045 8 governed changes · top 7 shown
01
HIGH IMPORTANCE Cash 50TH HISTORICAL PCTL · N=2
Cash & equivalents decreased 95.2% Cash & equivalents changed -95.2% from the comparable as-filed period.
Why this ranks here · [email protected] $55.5M → $2.6M Comparable → current
02
MEDIUM IMPORTANCE Inventory 25TH HISTORICAL PCTL · N=4
Inventory increased 17.6% Inventory changed +17.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Why this ranks here · [email protected] $2.4M → $2.8M Comparable → current
03
HIGH IMPORTANCE Net Income 0TH HISTORICAL PCTL · N=2
Net income decreased 73.0% Net income changed -73.0% from the comparable as-filed period.
Why this ranks here · [email protected] $12.9M → $3.5M Comparable → current
04
HIGH IMPORTANCE Operating Income 67TH HISTORICAL PCTL · N=3
Operating income increased 81.5% Operating income changed +81.5% from the comparable as-filed period.
As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 2.47% +248.9% ↑ Capital expenditure $1.3M +221.9% ↑ Cash & equivalents $2.6M +0.0% ↑ Debt $0 — Free-cash-flow proxy $13.0M +34.7% ↑ Gross margin 89.57% -0.2% ↓ Interest income -$1.8M -59.5% ↓ Inventory $2.8M +6.9% ↑
ACTIVE TRACE Revenue IIIV · as filed with the SEC · reported-date aware
PASS · 24 OBS
Capex / revenue Q3 / 2026-06-30 2.47% +248.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q3 / 2026-06-30 $1.3M +221.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q3 / 2026-06-30 $2.6M +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Debt FY / 2025-09-30 $0 Comparable n/a Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q3 / 2026-06-30 $13.0M +34.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin Q2 / 2024-03-31 89.57% -0.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest income Q3 / 2026-06-30 -$1.8M -59.5% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory Q3 / 2026-06-30 $2.8M +6.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q3 / 2026-06-30 $3.5M +58.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q3 / 2026-06-30 $14.3M +42.3% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q3 / 2026-06-30 -1.68% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Revenue Q3 / 2026-06-30 $53.1M -7.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
10-Q Aug 7, 2026 Period Jun 30, 2026 0001728688-26-000045SEC ↗ 8-K Aug 6, 2026 Period Aug 6, 2026 0001728688-26-000041SEC ↗ 8-K Jun 2, 2026 Period Jun 2, 2026 0001728688-26-000037SEC ↗ 4 May 14, 2026 Period May 14, 2026 0001072783-26-000002SEC ↗ 8-K May 12, 2026 Period May 12, 2026 0001728688-26-000034SEC ↗ 10-Q May 8, 2026 Period Mar 31, 2026 0001728688-26-000032SEC ↗ 8-K May 7, 2026 Period May 7, 2026 0001728688-26-000029SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗